ConductScience.org, home

Library / Genes

HPX: hemopexin

1 protein, 147 patents, 0 drugs, 0 trials, 2,577 NIH grants and 5,647 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolHPXHGNC
NamehemopexinHGNC
NCBI Gene ID3263NCBI Gene
HGNC IDHGNC:5171HGNC
EnsemblENSG00000110169NCBI Gene
AliasesHXNCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P02790Hemopexin4620Ensembl, GeneID, HGNCUniProt

Patents 147

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1448902P02790Espacenet
WO 2025257801 A12025-12-181P02790Espacenet
EP 4650780 A22025-11-192543P02790Espacenet
EP 4641201 A22025-10-292131P02790Espacenet
JP 2025147176 A2025-10-066562P02790Espacenet
JP 2025529142 A2025-09-046608P02790Espacenet
US 12371689 B22025-07-296608P02790Espacenet
EP 4587839 A22025-07-236P02790Espacenet
JP 2025517969 A2025-06-122131P02790Espacenet
JP 2025517970 A2025-06-122543P02790Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 2577

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA051008Georgetown University Lombardi Comprehensive Cancer Center Support Grant202,025NIH's project files
P01CA092584Structural Cell Biology of DNA Repair Machines72,025NIH's project files
R01AI073843Pathobiology of heme inducible transporters in Gram positive pathogens72,025NIH's project files
P30CA046934University of Colorado Cancer Center Support Grant62,025NIH's project files
R01CA160254Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach62,025NIH's project files
R01DK074797Inter-organ signaling in heme metabolism and organismal homeostasis.62,025NIH's project files
P20GM113226Hepatobiology and Toxicology COBRE52,025NIH's project files
P30AR070549Cincinnati Rheumatic Diseases Resource Center52,025NIH's project files
P30CA008748Cancer Center Support Grant52,025NIH's project files
P30CA014520UW Comprehensive Cancer Center Support52,025NIH's project files

Papers 5647

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42809521PubTator, text miningPubMed
42777977PubTator, text miningPubMed
42695891PubTator, text miningPubMed
42611616PubTator, text miningPubMed
42573709PubTator, text miningPubMed
42481899PubTator, text miningPubMed
42441716PubTator, text miningPubMed
42402173PubTator, text miningPubMed
42383071PubTator, text miningPubMed
42326790PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license